Përfitimet shëndetësore të shafranit të Indisë
DOI:
https://doi.org/10.55312/op.vi2.4466Abstract
Shafrani i Indisë është një erëz me origjinë indiane, e cila si përbërës aktiv përmban kurkuminën. Prej kohësh veçohet për efektet e saj pozitive në shëndetin e individëve që e përdorin rregullisht. Shumë studime botërore kanë patur në fokus këtë erëz, duke shpjeguar të mundshëm me të cilat ajo vepron në disa patologji.Keywords:
shafrani i Indisë, kurkumina, antikancerogjen, antioksidues, antiinfl amator, antiseptik.Downloads
References
-
J. S. Jurenka. Anti-infl ammatory Properties of Curcumin, a Major Constituent of Curcuma longa: A Review of Preclinical and Clinical Research. Alternative Medicine Review, 14 (2), 2009.
-
www.clinicaltrials.gov, A service of the U.S. National Institutes of Health, 126 studies about Curcumin.
-
J. Ravindran, S. Prasad, and B.B. Aggarwal. Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively? The AAPS Journal, 11 (3), 2009.
-
Sharma RA, Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. (2001).
-
Cheng AL, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions . Anticancer Res. (2001).
-
Skrzypczak-Jankun E, Structure of curcumin in complex with lipoxygenase and its signifi cance in cancer. Int J Mol Med. (2003).
-
Zhou H, Beevers CS, Huang S The targets of curcumin . Curr Drug Targets. (2011).
-
Belcaro G, Effi cacy and safety of Meriva®, curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients . Altern Med Rev. (2010).
-
Agarwal KA, Effi cacy of turmeric curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebocontrolled study . Surg Endosc. (2011).
-
www.examine.com an independent on supplementation and nutrition.
References
J. S. Jurenka. Anti-infl ammatory Properties of Curcumin, a Major Constituent of Curcuma longa: A Review of Preclinical and Clinical Research. Alternative Medicine Review, 14 (2), 2009.
www.clinicaltrials.gov, A service of the U.S. National Institutes of Health, 126 studies about Curcumin.
J. Ravindran, S. Prasad, and B.B. Aggarwal. Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively? The AAPS Journal, 11 (3), 2009.
Sharma RA, Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. (2001).
Cheng AL, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions . Anticancer Res. (2001).
Skrzypczak-Jankun E, Structure of curcumin in complex with lipoxygenase and its signifi cance in cancer. Int J Mol Med. (2003).
Zhou H, Beevers CS, Huang S The targets of curcumin . Curr Drug Targets. (2011).
Belcaro G, Effi cacy and safety of Meriva®, curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients . Altern Med Rev. (2010).
Agarwal KA, Effi cacy of turmeric curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebocontrolled study . Surg Endosc. (2011).
www.examine.com an independent on supplementation and nutrition.
Shqip
English
Italiano
